Back
Medpace Holdings, Inc. (MEDP)
Life Sciences Tools & ServicesMEDP · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$531.99
−2.62%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$15.28
ROE
77.3%
Gross margin
71.9%
Debt/Equity
0.24x
Revenue growth
26.5%
Medpace Holdings, Inc. — company intelligence
Earnings surprises
Q1 2026$4.28 vs $3.96 est+8.1%
Q4 2025$4.67 vs $4.26 est+9.6%
Q3 2025$3.86 vs $3.59 est+7.5%
Q2 2025$3.10 vs $3.02 est+2.6%
Analyst consensus · 20 analysts
9 Buy10 Hold1 Sell
Updated Jul 8, 2026
Insider activity · 90 days
14 buys0 sellsnet +81,660 shares
McCarthy Cornelius P. IIIother 28 · Jun 30, 2026
Kraft Robert O.other 33 · Jun 30, 2026
Carley Brian Tother 36 · Jun 30, 2026
Recent SEC filings
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJul 2, 2026
4 — Insider transaction reportJul 2, 2026
Latest news
Medpace Growth Trends Show How CRO Demand Is Shifting in 2026 — Yahoo · 3d ago
This Truist Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday — Benzinga · 4d ago
Jefferies Downgrades Medpace Holdings to Hold, Raises Price Target to $515 — Benzinga · 4d ago
Medpace Stock Outlook Turns on Backlog Quality and Cancellations — Yahoo · 4d ago
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Medpace Holdings, Inc.
Weekly undervalued picks (like MEDP)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.